Voß F - Search Results

1

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.

Buhl R, Magder S, Bothner U, Tetzlaff K, Voß F, Loaiza L, Vogelmeier CF, McGarvey L. Buhl R, et al. Among authors: voss f. Respir Med. 2017 Jan;122:58-66. doi: 10.1016/j.rmed.2016.11.011. Epub 2016 Nov 14. Respir Med. 2017. PMID: 27993292 Free article. Clinical Trial.

2

Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis.

Schlueter M, Gonzalez-Rojas N, Baldwin M, Groenke L, Voss F, Reason T. Schlueter M, et al. Among authors: voss f. Ther Adv Respir Dis. 2016 Apr;10(2):89-104. doi: 10.1177/1753465815624612. Epub 2016 Jan 8. Ther Adv Respir Dis. 2016. PMID: 26746383 Free PMC article. Review.

3

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.

Singh D, Gaga M, Schmidt O, Bjermer L, Grönke L, Voß F, Ferguson GT. Singh D, et al. Among authors: voss f. Respir Res. 2016 Jun 18;17(1):73. doi: 10.1186/s12931-016-0387-7. Respir Res. 2016. PMID: 27316465 Free PMC article.

4

Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies.

Maltais F, Kirsten AM, Hamilton A, De Sousa D, Voß F, Decramer M. Maltais F, et al. Among authors: voss f. Respir Res. 2016 Jul 6;17(1):77. doi: 10.1186/s12931-016-0389-5. Respir Res. 2016. PMID: 27383762 Free PMC article. Clinical Trial.

5

The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies.

Ichinose M, Taniguchi H, Takizawa A, Grönke L, Loaiza L, Voß F, Zhao Y, Fukuchi Y. Ichinose M, et al. Among authors: voss f. Int J Chron Obstruct Pulmon Dis. 2016 Aug 29;11:2017-27. doi: 10.2147/COPD.S110389. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27621608 Free PMC article. Clinical Trial.

6

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO^® and OTEMTO^® studies: a subgroup analysis by age.

Ferguson GT, Karpel JP, Clerisme-Beaty E, Grönke L, Voß F, Buhl R. Ferguson GT, et al. Among authors: voss f. Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2701-2710. doi: 10.2147/COPD.S108758. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27843306 Free PMC article.

7

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.

Ferguson GT, Karpel J, Bennett N, Clerisme-Beaty E, Grönke L, Voß F, Buhl R. Ferguson GT, et al. Among authors: voss f. NPJ Prim Care Respir Med. 2017 Feb 2;27(1):7. doi: 10.1038/s41533-016-0002-x. NPJ Prim Care Respir Med. 2017. PMID: 28154373 Free PMC article. Clinical Trial.

8

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat^® device for maintenance treatment of COPD: comparison with the long-acting β₂-agonist formoterol.

Koch A, Watz H, Maleki-Yazdi MR, Bothner U, Tetzlaff K, Voß F, McGarvey L. Koch A, et al. Among authors: voss f. NPJ Prim Care Respir Med. 2017 Oct 23;27(1):60. doi: 10.1038/s41533-017-0059-1. NPJ Prim Care Respir Med. 2017. PMID: 29061968 Free PMC article. Clinical Trial.

9

β-Blockers in COPD: A Cohort Study From the TONADO Research Program.

Maltais F, Buhl R, Koch A, Amatto VC, Reid J, Grönke L, Bothner U, Voß F, McGarvey L, Ferguson GT. Maltais F, et al. Among authors: voss f. Chest. 2018 Jun;153(6):1315-1325. doi: 10.1016/j.chest.2018.01.008. Epub 2018 Jan 31. Chest. 2018. PMID: 29355547 Free article. Clinical Trial.

10

Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials.

Ferguson GT, Buhl R, Bothner U, Hoz A, Voß F, Anzueto A, Calverley PMA. Ferguson GT, et al. Among authors: voss f. Respir Med. 2018 Oct;143:67-73. doi: 10.1016/j.rmed.2018.08.012. Epub 2018 Aug 28. Respir Med. 2018. PMID: 30261995 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page